Resources library
Welcome to our resource library. We invite you to explore and view our extensive resources and information.
OXB Global Brochure 2026
This brochure highlights OXB's capabilities, showcasing our platforms, technical expertise, and client-centric ways of working across the cell and gene therapy journey.
View Resource >
Efficient In Vivo Generation of CAR T Cells using a Retargeted Fourth-Generation Lentiviral Vector
View details >Commercial Capabilities One Pager
Learn how OXB supports the transition from late-stage development to commercial supply through proven expertise in process characterisation, PPQ, regulatory submissions and commercial-scale GMP manufacturing.
View details >
Infographic: The 7 Regulatory Milestones Every Viral Vector Developer Should Plan For
A practical visual roadmap outlining the seven key regulatory milestones viral vector developers should consider from early development through lifecycle management.
View details >
5 Questions with… Melanie Kearney
Quality is about more than compliance. It's about building confidence at every stage of development. In this edition of 5 Questions with..., Dr. Melanie Kearney, SVP, Global Head of Quality at OXB, explores why Quality should be embedded from the very beginning of a cell and gene therapy programme.
View Resource >
Structural Analysis of Recombinant AAV Vector Genomes at Single-Molecule Resolution
This paper presents a long-read analysis pipeline for accurately classifying recombinant AAV genome heterogeneity to improve vector characterization and design.
View details >
5 Questions with… Ceri Schofield
How can Quality accelerate programme success while reducing risk? In this edition of 5 Questions with..., Ceri Schofield, VP and Head of Quality at OXB, shares her perspective on the increasingly strategic role of Quality in viral vector development.
View Resource >